Sentence examples for id administration from inspiring English sources

No significant differences in the occurrence of systemic reactions were detected (17.7 % in the ID group vs 18.2 % in the IM group) with a pooled RR = 1.00 (95 % CI = 0.67 -1.51), whereas ID administration caused significantly more injection site reactions with a mean frequency of 46%% in the ID group compared to 22%% in the IM group, with a pooled RR = 1.89 (95 % CI = 1.40 -2.57).

In this study, chimeric hyaluronidases were designed, prepared and tested for assisting biopharmaceuticals in ID administration in mice as replacement of SC administration.

In mice, we demonstrate that microneedle-mediated delivery of ChAd63.ME-TRAP induced similar numbers of transgene-specific CD8+ T cells compared to intradermal (ID) administration with needle-and-syringe, following a single immunisation and after a ChAd63/MVA heterologous prime-boost schedule.

We have shown that the intradermal (ID) administration of an HIV-1 lipopeptide candidate vaccine (LIPO-4) is well tolerated in healthy volunteers, with one fifth the IM dose delivered by this route inducing HIV-1-specific CD8+ T-cell responses of a magnitude and quality similar to those achieved by IM administration.

Structure-activity relationships (SAR) studies of 4 6 were performed, leading to identification of the nanomolar-level EP1 antagonist 4c, which exhibited good pharmacological effect through intraduodenal (id) administration in a 17-phenyltrinor prostaglandin E2-induced bladder contraction model in rats.

Participants given TIV ID provided favorable responses to questions about their experiences with ID administration.

Recent limitations in supplies of RV in the USA reopened discussions on the more efficient use of available biologics, including utilization of more stringent risk assessments, and potential ID RV administration.

In 1997, World Health Organization (WHO) recommended intra-dermal (ID) TCV administration in resource-poor setting [ 10].

The higher frequency of local reactions after ID and SC administration and the lack of sufficient evidence to show that there were any differences in immunogenicity by route of administration do not support changing route of administration for the rAd5 boost.

Similarly, we observed that the SCHU S4 ΔkdtA deletion mutant showed marked attenuation (Table 3), but the immunized mice did not show any extended time to death when they 5 to 6 weeks later were challenged by ID or aerosol administration of approximately 10 CFU of SCHU S4.

Hence, availability of healthcare provider for ID route of administration would not be an issue if the model is emulated elsewhere in the country in similar setting.